Agenda:
8:00 am – 8:30 am WELCOME & INTRODUCTION
Prof. Rebecca Carrier, Professor and Associate Chair for Research, Chemical Engineering, Northeastern University
Dr. Cornell Stamoran, Founder, Catalent Institute
8:30 am – 9:05 am IMPORTANCE OF API CHARACTERIZATION FOR IMPROVING DEVELOPABILITY OF SMALL MOLECULES
Dr. Chris Towler, Senior Fellow, Novartis Institutes for BioMedical Research
9:05 am – 9:40 am MODELING THE PHARMACOKINETIC CHALLENGES OF ORAL SMALL MOLECULE DRUGS
Dr. Katarina Vulic, Senior Scientist, Novartis Institutes for BioMedical Research
9:40 am – 9:50 am BREAK
9:50 am – 10:30 am FORMULATION STRATEGIES TO OVERCOME ORAL BIOAVAILABILITY CHALLENGES OF SMALL MOLECULE DRUGS
Mr. Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions
10:30 am – 11:05 am MECHANISTIC STUDIES AND MODELING TO PREDICT THE IMPACT OF LIPIDS ON ORAL ABSORPTION
Prof. Rebecca Carrier, Northeastern University
11:05 am – 12:00 pm AUDIENCE APPLIED LEARNING CHALLENGE- PART 1 AM SPEAKERS
12:00 pm – 1:00 pm NETWORKING LUNCH & MEET THE EXPERTS
1:00 pm – 1:35 am CMC AND QUALITY CONSIDERATIONS
1:35 pm – 2:10 pm INSIGHTS AND STRATEGIES TO INCORPORATE PATIENT FOCUSED DESIGN
Dr. Cornell Stamoran, Founder, Catalent Institute
2:10 pm – 2:45 pm STRATEGIES FOR PROGRESSING TO PHASE I FORMULATIONS TO IMPROVE YOUR SPEED TO AND SUCCESS IN THE CLINIC
Dr. Manuel Sanchez-Felix, Senior Fellow, Novartis Institute for Biomedical Research
2:45 pm – 3:00 pm BREAK
3:00 pm – 4:00 pm AUDIENCE APPLIED LEARNING CHALLENGE- PART 2 PM SPEAKERS CONCLUDING REMARKS
Dr. Ronak Savla, Scientific Affairs Manager, Catalent Pharma Solutions